References
- Lundberg C, Engquist S. Localization of bacteria and the cause of tissue destruction in maxillary sinusitis. Acta Otolaryngol (Stockh) 1984; Suppl. 407: 30–32.
- Karma P, Jokipii L, Sipila P, Luotonen J, Jokipii AM. Bacteria in chronic maxillary sinusitis. Arch Otolaryngol 1979; 105: 386–390.
- Su WY, Chen L, Shnian YH, Wei-Fu T. Bacteriological study in chronic maxillary sinusitis. Laryngoscope 1983; 93: 931–934.
- Gwaltney J, Sydnor A, Sande M. Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol 1981; 90 (Suppl 84) 68–71.
- Bill NJ, Washington JA. Comparison of in vitro activity of cephalexin, cephradine and cefaclor. Antimicrob Agents Chemother 1977; 11: 470–474.
- Scheld WW, Korzenowski OM, Sande MA. In vitro susceptibility studies with cefaclor and cephalexin. Antimicrob Agents Chemother 1977; 12: 290–292.
- Sanders CC. In vitro studies with cefaclor, a new oral cephalosporin. Antimicrob Agents Chemother 1977; 12: 490–497.
- Bach VT, Khurau MM, Thadepalli H. In vitro activity of cefaclor against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1978; 13: 210–213.
- Axelsson A, Brorson JE. The concentration of antibiotics in sinus secretions – Ampicillin, cephradine and erythromycinestolate. Ann Otol 1974; 83: 323–330.